Israel, champion of bio-convergence: Ben-Gurion University and the Soroka Medical Center.

Ben-Gurion University of the Negev (BGU) and Soroka Medical Center announced a strategic collaboration for the development of new technologies in the field of bio-convergence (a field that combines biology with computer technologies and engineering ). The projects selected as part of this collaboration will be funded by the British philanthropic fund Rosetrees Trust.

BGN Technologies, BGU’s technology transfer company, will support projects from their launch in various aspects of commercialization, including intellectual property protection and business development activities.

The collaboration is announced ahead of Biomed Israel 2022, Israel’s leading international life science and health technology conference, to be held May 10-12, 2022 at the David InterContinental Hotel in Tel Aviv, Israel.

Prof. Raz Jelinek, Vice President and Dean of Research and Development at BGU, said: “The collaboration between Prof. Alfonta and Dr. Staretz-Chacham is an excellent example of breakthroughs in the field of bio-convergence. which can be achieved by joining forces of a leading university and a leading medical center. BGU stands out in the Israeli academic landscape for its unique integration of engineering and biopharmaceuticals. It is only natural that we combine our strengths in engineering with the medical school and with the adjacent state-of-the-art medical center, Soroka. The synergy of strengths and talents can help to develop revolutionary solutions in the field of bio-convergence, which aims to address the important challenges of the global health system and the biopharmaceutical industry. »

The collaboration between the two institutions aligns with the vision of the Israel Innovation Authority, and combines the excellence of BGU researchers in the various fields of engineering, including artificial intelligence, learning automation and big data, as well as in the life sciences, with the world-class knowledge and experience of Soroka’s physicians. A joint team from the two institutes mapped the daily medical needs of Soroka on the one hand, and the current challenges of the pharma and HealthTech industries on the other. In response to these needs and challenges, the collaboration is developing applied bio-convergence projects with strong potential for future commercialization. These projects associate research teams in engineering, biology and medicine from the BGU with clinicians from Soroka.

Josh Peleg, CEO of BGN Technologies, said: “In addition to the synergy between the disciplines and strengths of both institutions, which drives innovation in the field of bio-convergence, this unique collaboration also emphasizes the applicable technology. The first step is to identify the needs of current medicine, both in hospitals and in the biopharmaceutical industry, after which we turn to researchers in order to find a solution to the problem. The involvement of BGN Technologies from the early stages of project selection will maximize the commercial feasibility of funded inventions. In addition, we will support each project in terms of business development and intellectual property protection. Our role is to bridge the gap between academia and industry”.

Bio-convergence is a multidisciplinary combination of biology, engineering, electronics, artificial intelligence, computational biology, physics, nanotechnology, materials science and genetic engineering. The synergy between biology and engineering is considered today as the vanguard of science and medical development.

The Israel Innovation Authority is championing bio-convergence with grants that will enable the growth of this field in Israel and the creation of a competitive industry with high economic value and international significance.

Source : Spoke & Israel Valley

We would love to thank the writer of this article for this awesome material

Israel, champion of bio-convergence: Ben-Gurion University and the Soroka Medical Center.


Visit our social media profiles and also other pages related to themhttps://www.ai-magazine.com/related-pages/